Clinical Trials Directory

Trials / Completed

CompletedNCT05517083

Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer

Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Advanced Non-small Cell Lung Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Pusan National University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the relevance of intratumoral washing for detection of EGFR mutation (including T790M positivity).

Detailed description

This is a prospective, single-arm, open-label study to assess evaluate the relevance of intratumoral washing by ultrathin bronchoscopy (outer diameter; 3mm) for detection of EGFR mutation (including T790M positivity) using cobas real-time PCR and droplet digital PCR (DDPCR) in patients with NSCLC.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltarthin bronchoscopy with intratumoral washingEach subject with NSCLC will undergo bronchooscopic procedure. First, ultrathin bronchoscope is inserted and placed within tumor under radial EBUS, virtual bronchoscopic navigation, and fluoroscopy guidance. Then, intratumoral washing is performed. Subsequently, transbronchial lung biopsy is performed under radial EBUS, virtual bronchoscopic navigation, and fluoroscopy guidance.

Timeline

Start date
2022-04-01
Primary completion
2023-09-30
Completion
2024-12-31
First posted
2022-08-26
Last updated
2025-08-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05517083. Inclusion in this directory is not an endorsement.

Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer (NCT05517083) · Clinical Trials Directory